| Views | |
|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 230 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 18 | 8 | 4 | 34 | 16 | 14 | 10 |
| Views | |
|---|---|
| EMBR_EMBR202154305.pdf | 220 |
